233 S. 10th Street
Room 802
Philadelphia, PA 19107
(215) 503-4564
(215) 923-2117 fax
Room 802
Philadelphia, PA 19107
(215) 503-4564
(215) 923-2117 fax
Most Recent Peer-reviewed Publications
- Polyvalent side chain peptide-synthetic polymer conjugates as HIV-1 entry inhibitors
- Nucleoporin Nup50 stabilizes closed conformation of armadillo repeat 10 in importin α5
- Design of a potent D-peptide HIV-1 entry inhibitor with a strong barrier to resistance
- Asymmetric deactivation of HIV-1 gp41 following fusion inhibitor binding
- Interactions of HIV-1 inhibitory peptide T20 with the gp41 N-HR coiled coil
- Topical application of entry inhibitors as "virustats" to prevent sexual transmission of HIV infection
- Neutralization of Botulinum neurotoxin by a human monoclonal antibody specific for the catalytic light chain
- Hybridoma populations enriched for affinity-matured human IgGs yield high-affinity antibodies specific for botulinum neurotoxins
- A human monoclonal antibody that binds serotype A botulinum neurotoxin
- C34, a membrane fusion inhibitor, blocks HIV infection of Langerhans cells and viral transmission to T cells
- Kinetic dependence to HIV-1 entry inhibition
- HIV-1 gp41 as a target for viral entry inhibition
- Targeting therapeutics to an exposed and conserved binding element of the HIV-1 fusion protein
- Protein design of an HIV-1 entry inhibitor